| Primary |
| Drug Use For Unknown Indication |
83.3% |
| Vulvovaginal Mycotic Infection |
16.7% |
|
| Death |
50.0% |
| Oedema |
33.3% |
| Dysuria |
16.7% |
|
| Secondary |
| Hypertension |
23.1% |
| Asthma |
12.8% |
| Oral Candidiasis |
7.7% |
| Allergenic Desensitisation Procedure |
5.1% |
| Immunosuppression |
5.1% |
| Infection Prophylaxis |
5.1% |
| Muscle Spasms |
5.1% |
| Rash Macular |
5.1% |
| Respiratory Disorder |
5.1% |
| Urticaria |
5.1% |
| Angina Pectoris |
2.6% |
| Arthritis |
2.6% |
| Glaucoma |
2.6% |
| Hypersensitivity |
2.6% |
| Multiple Allergies |
2.6% |
| Pain |
2.6% |
| Product Used For Unknown Indication |
2.6% |
| Stress |
2.6% |
|
| Drug Hypersensitivity |
20.0% |
| Feeling Cold |
20.0% |
| Pyrexia |
20.0% |
| Urticaria |
20.0% |
| Vestibular Disorder |
20.0% |
|
| Concomitant |
| Drug Use For Unknown Indication |
18.9% |
| Product Used For Unknown Indication |
17.1% |
| Multiple Myeloma |
10.4% |
| Pain |
5.7% |
| Hypertension |
5.7% |
| Renal Transplant |
5.5% |
| Prophylaxis Against Transplant Rejection |
5.3% |
| Prophylaxis |
5.0% |
| Depression |
3.6% |
| Nuclear Magnetic Resonance Imaging |
3.4% |
| Anxiety |
2.9% |
| Heart Transplant |
2.4% |
| Hiv Infection |
2.1% |
| Osteoporosis |
2.1% |
| Nausea |
1.9% |
| Asthma |
1.8% |
| Insomnia |
1.6% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Chronic Obstructive Pulmonary Disease |
1.5% |
| Non-small Cell Lung Cancer |
1.5% |
|
| Vomiting |
12.8% |
| Weight Decreased |
10.8% |
| Thrombocytopenia |
8.2% |
| White Blood Cell Count Increased |
6.2% |
| Pyrexia |
5.6% |
| Vision Blurred |
5.1% |
| Pneumonia |
4.6% |
| Wound Complication |
4.6% |
| Wound Infection |
4.6% |
| Renal Failure Acute |
4.1% |
| Transplant Rejection |
4.1% |
| Hyperglycaemia |
3.6% |
| White Blood Cell Count Decreased |
3.6% |
| Wound Secretion |
3.6% |
| Death |
3.1% |
| Pain |
3.1% |
| Postoperative Wound Infection |
3.1% |
| Renal Failure |
3.1% |
| Syncope |
3.1% |
| Toothache |
3.1% |
|
